Riskpilot← Back to searchSign inGet full accessFROGNERLEGENE AS
ASActiveOrg 920377092Dueveien 1, 2016 FrognerGeneral medical practice activities · NACE 8621Est. 20187 employees
Revenue 2025
NOK 3,9M
+7% vs 2024
EBITDA margin
14.9%
-7% vs 2024
Equity ratio
-0.1%
Financial strength
Net profit 2025
NOK 123K
-31% vs 2024
| Revenue | NOK 3,9M | +7% |
| EBITDA | NOK 579K | -7% |
| Net profit | NOK 123K | -31% |
| Total assets | NOK 5,3M | -3% |
| Equity | NOK -7K | +95% |
| Employees | 7 | — |
Legal name
FROGNERLEGENE AS
Org number
920377092
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
5. februar 2018
Share capital
NOK 30 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drift av legesenter, investering i eiendom og aksjer, samt alt annet som naturlig faller inn under dette.
Address
Dueveien 1, 2016 Frogner
Phone
+4764838080
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 670 | 3 860 | 3 135 | 3 613 | 3 881 |
| Staff expenses | −1 468 | −1 824 | −1 471 | −1 766 | −1 848 |
| EBITDA | 32 | 352 | 424 | 622 | 579 |
| Depreciation & amort. | −6 | −47 | −223 | −227 | −229 |
| EBIT | 26 | 305 | 201 | 395 | 350 |
| Net financials | −0 | −16 | −232 | −218 | −227 |
| Profit before tax | 26 | 290 | −31 | 177 | 123 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 26 | 290 | −31 | 177 | 123 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 233 | 6 324 | 5 640 | 5 500 | 5 337 |
| Equity | −265 | −275 | −306 | −129 | −7 |
| Long-term debt | 0 | 3 193 | 5 556 | 5 212 | 4 949 |
| Short-term debt | 499 | 3 406 | 390 | 417 | 395 |
| Total debt | 499 | 6 600 | 5 946 | 5 629 | 5 344 |
EBITDA margin
14.9%
This company
15.8%
Market median
-6% vs market
20212025
Equity ratio
-0.1%
This company
38.2%
Market median
-100% vs market
20212025
Return on equity
12263000.0%
This company
18.4%
Market median
+66646639% vs market
20212025
Net profit margin
3.2%
This company
8.1%
Market median
-60% vs market
20212025
Asset turnover
0.73×
This company
1.12×
Market median
-35% vs market
20212025
Debt / equity
782.36×
This company
0.62×
Market median
-126087% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EB Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FROGNERLEGENE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Esben Boberg Skotte | Chief Executive Officer | 0 companies |
| Dina Wikstrøm | Board of Directors | 0 companies |
| Hosein Sohrabi | Board of Directors | 0 companies |